The DKK1 changes were not associated with the improvement of FPG in post hoc analysis of an RCT involving 92 patients with T2DM, who were assigned to acarbose or metformin treatment for 12 weeks [78]. This evidence concerns the gene DKK1 and type 2 diabetes mellitus.